CrossRoads® Extremity Systems surgical tools and implants are designed to address a broad variety of bunion deformities. The Tennessee-based foot and ankle company has officially announced that they will be joining the devices offered by DePuy Synthes, Johnson & Johnson’s orthopedics-focused subsidiary. DePuy Synthes announced the acquisition of the foot and ankle surgical device maker
A world first: using a nerve-stimulating device implanted into the spinal cord and controlled by a tablet, Swiss researchers have enabled three paraplegic patients to stand and walk again. Since 2018, technological innovation has proven that paralysis from spinal cord injury may be partly reversible, as using electrical implants on the spine seem to encourage
kamranElectrode Spinal Cord Implant Restores Motor Functions Post-Paralysis
Within the U.S. Orthopedic Biomaterials market, multiple segments are discussed including bone graft substitutes, cellular allografts, and growth factors. Bone graft substitutes are designed to fill bone voids or act as extenders, thereby eliminating or decreasing the need for autograft harvesting. On the other hand, cellular allografts consist of allograft bone combined with adipose-derived mesenchymal
Emma MatrickOrthopedic Biomaterial Devices: Top Brands per Segment in the U.S.
iData is excited to announce one of our brand-new 2022 market reports on the U.S. orthopedic biomaterials market. As expected, 2020 was an unusual year mainly due to the global COVID-19 pandemic, which caused a 6.7% decrease in the U.S. Orthopedic Biomaterials Market from 2019 to 2020. Despite a large majority of orthopedic surgeries
Emma Matrick$4.7 Billion Dollars: How the U.S. Orthopedic Biomaterials Market is Growing
iData Research has conducted a thorough analysis on the varying market trends that follow the Minimally Invasive (MIS) Spinal Implants Market in Europe in comparison to the Open Spinal Implants Market. Though the two procedures exemplify similar characteristics with regard to their procedures, their market trends are drastically different and are forecasted to grow at
kamranMIS Spinal Implants vs. Open Spinal Implants: Who Will Dominate the Market in 2022?
A Top-Level Analysis of Europe’s MDR iData’s analysts work extensively to collect data and insight from a variety of resources to create both syndicated and custom research reports for their successful clients world-wide. Owing to their in-depth understanding of the markets and first-hand experience with the appropriate data, our analysts have looked into the effects
kamranWith The MDR in Full Effect, How Will The Orthopedic Trauma Market Cope?
iData Research has conducted a thorough analysis on various positive and negative trends affecting the Minimally Invasive (MIS) Spinal Implants Markets in Mexico, Brazil, and Argentina. Though the three countries have exemplified similar characteristics in demographic features and trends, learning more in-depth about a country’s market can be advantageous for potential future investment opportunities. WHAT
Emma MatrickTrends Limiting and Driving the MIS Spinal Implants Markets In Mexico, Brazil, and Argentina
Bunions (also referred to as hallux valgus) are bony bumps that typically form on the joint at the base of your big toe, causing your big toe to be pulled towards your smaller toes. In the United States alone, there is a high incidence of bunions with approximately 5 million people suffering from them to
Emma MatrickMIS Bunion Devices: Top Brands per Segment in the U.S.
iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Due to their in-depth understanding of the markets and their first-hand experience with the data, we have asked some insightful questions on the European market for orthopedic biomaterials to assist you in making better strategic decisions. WHAT ARE ORTHOPEDIC
Emma MatrickAnalyst Q&A: Orthopedic Biomaterials and the European Market
Arthroscopy is one of the most common out-patient procedures. In recent years, there has been an increasing number of arthroscopies being performed in physician-owned ambulatory surgery centers (ASCs). Previously the U.S. arthroscopic device market was valued at nearly $1.5 billion and is expected to reach $2.1 billion by 2025. What is causing the market to
Emma MatrickWhat Is Causing an Increase in the U.S. Arthroscopic Device Market?